Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Christodoulou, K.
Right arrow Articles by Middleton, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christodoulou, K.
Right arrow Articles by Middleton, L. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 635-640, Copyright © 1997 by Oxford University Press

ARTICLES

Mapping of the familial infantile myasthenia (congenital myasthenic syndrome type Ia) gene to chromosome 17p with evidence of genetic homogeneity

K Christodoulou, M Tsingis, F Deymeer, P Serdaroglu, C Ozdemir, A Al-Shehab, C Bairactaris, I Mavromatis, I Mylonas, A Evoli, K Kyriallis and LT Middleton
The Cyprus Institute of Neurology and Genetics, Nicosia.

Familial infantile myasthenia is an autosomal recessive disorder, recently classified as congenital myasthenic syndrome type Ia. Onset of symptoms is at birth to early childhood with significant myasthenic weakness and possible respiratory distress, followed later in life by symptoms of mild to moderate myasthenia. Thirty-six patients of 12 families, seven of them consanguineous, were used to map the familial infantile myasthenia gene. A combination of linkage search through the genome, DNA pooling and homozygosity mapping were employed resulting in the localisation of this disease locus to the telomeric region of chromosome 17p. A maximum lod score of 9.28 at theta = 0.034 was obtained between the disease locus and marker locus D17S1537. Haplotype analysis showed all families to be consistent with linkage to this region thus providing evidence for genetic homogeneity of familial infantile myasthenia. Multipoint linkage analysis mapped the disease gene in the approximately 4.0 cM interval between marker loci D17S1537 and D17S1298 with a maximum multipoint lod score of 12.07. Haplotype analysis and homozygosity by descent in affected individuals of the consanguineous families revealed results in agreement with the confinement of the familial infantile myasthenia region within the interval between marker loci D17S1537 and D17S1298.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
J.-F. Subra, B. Cautain, E. Xystrakis, M. Mas, D. Lagrange, H. van der Heijden, M.-J. van de Gaar, P. Druet, G. J. Fournie, A. Saoudi, et al.
The Balance Between CD45RChigh and CD45RClow CD4 T Cells in Rats Is Intrinsic to Bone Marrow-Derived Cells and Is Genetically Controlled
J. Immunol., March 1, 2001; 166(5): 2944 - 2952.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. Middleton, K. Ohno, K. Christodoulou, J. Brengman, M. Milone, V. Neocleous, P. Serdaroglu, F. Deymeer, C. Ozdemir, A. Mubaidin, et al.
Chromosome 17p-linked myasthenias stem from defects in the acetylcholine receptor {epsilon}-subunit gene
Neurology, September 1, 1999; 53(5): 1076 - 1076.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.